A drug to boost female libido
Men have viagra since 1998 to increase their sexual abilities. Women will have flibanserin soon to boost their libido.
Tested on several thousands of women suffering from disorders of desire, this drug has significantly improved their sex lives, according to studies presented recently at the 12th Congress of the European Society for Sexual Medicine.
After the advent of the little blue pill and its competitors, which have transformed the treatment of male sexual disorders and conquered a billion dollar market, pharmaceutical companies began looking for their female equivalents.
But the challenge has proved to be more difficult than expected, partly because sexuality is much more complex in women than in men. A testosterone patch called Intrinsa has been marketed in 2007, to decrease the desire after surgical menopause.
Outside this narrow framework, the notion of female sexual dysfunction is not unanimous. For skeptics, it is just a business idea of pharmaceutical companies to sell new drugs. But this is a real disease, but frequently ignored, say experts.
According to the trials on the flibanserin, it is not known much about female sexuality because there has been little academic research in this area and some taboos. Like in case of Viagra, the benefits of flibanserin on libido were discovered incidentally.
This product acts on the central nervous system at the level of serotonin receptors. It was initially used as an antidepressant, but its effects on female desire appeared to be more convincing.
The studies have been conducted in the United States and Europe on premenopausal women suffering from "hypoactive sexual desire" (DSH). Unknown to the general public and even doctors, this term is jargon used in textbooks of psychiatry to define sexual disorders characterized by a lack of desire. During 24 weeks, volunteers were treated with 100 mg of flibanserin or placebo.
To assess its effects in a field as complex as female sexuality, the investigators used an electronic logbook. After several weeks, these parameters were statistically improved in women treated with flibanserin.
The effects are undeniable, but beware, this is not the same concept as for erectile dysfunction. Here it will be a daily treatment for a long period.
Marketing is announced around 2011. A deadline that does not confirm the laboratory Boehringer Ingelheim, which wants to be very cautious while awaiting additional results. A handful of other drugs with different modes of action are under study, in very preliminary phases of clinical or animal studies.
Recommended articles:
Cuba offers free penis implants
The "failure" affects sexual self-confidence
Statins against cholesterol: Still debated
Most recent in the category Human body:
- How to Control Human Body Inflammation
- Follow the Makeup Secrets to Look 10 Years Younger!
- Know About Human Body Inflammation!
- Eating strawberries would prevent ulcers
- Young fathers experience a drop in testosterone
- The first autologous human red blood cells from stem cells
- Good minerals to conserve energy
- Sperm has been recreated in the laboratory
Last comments
Most read - Human body
- The female brain is more active than male
- Female Sexual Dysfunction Creates More Issues Than You Realize
- Find time to practice physical exercise
- Retinitis pigmentosa: A protein for good eyesight found
- Artificial skin with a bright future
- Regenerative medicine: Printing the organs
- Getting bioartificial lungs
- The first permanent artificial heart implanted
- Doping: The growth hormone effective in sprinters
- A Chinese baby born with two heads
Top rated - Human body
- Chronic cough: Pepper to refine the diagnosis
- The intestinal flora, a "black box" to explore
- Genetic variants accelerate biological aging
- Stuttering has genetic origin
- Babies learn bilingualism from the womb
- Multiple sclerosis: the benefits of exercise
- Allergy: New in treatment
- Soon a vaccine against malaria for the pregnant?
- Genetic testing to determine anticoagulants dose
- Physical activity for a smooth recovery
No comments. Be the first to comment the article!